Wyeth, Neurome expand central nervous system disease research collaboration

By Angela McDaniels

Seattle, Nov. 21 - Neurome Inc. and Wyeth said they have expanded their discovery research collaboration, which is focused on the investigation of certain aspects of central nervous system diseases using Neurome's discovery technologies and expertise in quantitative neuropathology.

Neurome will evaluate the effectiveness of possible drug candidates as part of intervention studies in an animal model of neurodegenerative disease, the companies said.

Financial terms of the agreement were not disclosed.

Wyeth is a pharmaceutical company based in Madison, N.J., that develops consumer and animal health care products.

Neurome, based in La Jolla, Calif., is a discovery-stage biotechnology company that seeks therapeutic solutions to human neurodegenerative diseases.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.